Rapid Molecular Diagnostics: Better Tests, Better Care
Real-time automation improves utility for molecular technologies.
Read MorePosted by Jenny Lower | Jan 15, 2014 | Molecular Diagnostics |
Real-time automation improves utility for molecular technologies.
Read MorePosted by Steve Halasey | Jan 7, 2014 | Cancer, Pancreatic, Research |
Trovagene and US Oncology Research have joined forces to examine the utility of quantitative urine-based KRAS mutation detection and monitoring in pancreatic cancer patients.
Read MorePosted by Judy O'Rourke | Sep 23, 2013 | Cancer, Miscellaneous |
Technologies go to the next level in diagnosing hospital-acquired infections
Read MorePosted by Judy O'Rourke | Sep 3, 2013 | Molecular Diagnostics |
The two companies present powerful strategic synergies.
Read MorePosted by Judy O'Rourke | Aug 22, 2013 | Cancer, Miscellaneous, Research |
NIH-Funded Study Provides More Evidence Supporting Development of Noninvasive Tests
Read More